Global Radiopharmaceutical CDMO/CMO Services Market Size is valued at USD 2.9 Billion in 2024 and is predicted to reach USD 7.0 Billion by the year 2034 at a 9.2% CAGR during the forecast period for 2025-2034. Radiopharmaceutical drugs, introduced with radioactive isotopes, are pivotal in both diagnosing and treating medical conditions. These compounds emit detectable radiation, helping in the visualization of specific organs or tissues through ...
Report ID: 2472 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Advanced Therapy Medicinal Products CDMO Market Size is valued at 6.7 Billion in 2024 and is predicted to reach 26.6 Billion by the year 2034 at a 15.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The demand for personalized treatment strategies is a significant driver for the advanced therapy medicinal products market. Targeted sequencing offers opportunities to ...
Report ID: 1369 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Acquired Orphan Blood Disease Market Size is valued at USD 9.4 Billion in 2024 and is predicted to reach USD 26.1 Billion by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: A key trend in the market is the development of targeted therapies and personalized medicine approaches, which aim to provide more precise and efficient treatments for patients. The increasing...
Report ID: 1456 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Advanced Empty Capsule Market Size is valued at USD 1.9 Billion in 2024 and is predicted to reach USD 5.1 Billion by the year 2034 at a 10.6% CAGR during the forecast period for 2025-2034. Advanced Empty Capsules are used to deliver various kinds of drugs without altering their formulation. These capsules are designed so that they do not interfere with any drug formulation and ensure proper drug delivery. Growing incidence of chronic dis...
Report ID: 1233 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 185
Global mRNA Extraction and Purification Market Size is valued at USD 1105.2 Million in 2024 and is predicted to reach USD 7561.2 Million by the year 2034 at a 21.6% CAGR during the forecast period for 2025-2034. Purification and isolation or extraction processes are mandatory for all types of medical research. mRNA Purification and extraction are performed by using different kinds of methods. Many specialized methods are av...
Report ID: 1285 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Global GLP-1 Market Size is valued at USD 50.0 Bn in 2024 and is predicted to reach USD 141.9 Bn by the year 2034 at an 11.1% CAGR during the forecast period for 2025-2034. The glucagon-like peptide-1 receptor (GLP1R) is a crucial target in treating type 2 diabetes and obesity, given its significant role in regulating blood sugar levels and appetite. GLP-1, a hormone produced in the gut, enhances insulin secretion from pancreatic beta cells in r...
Report ID: 2592 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
The Synthetic Biology Market Size is valued at USD 17.67 Bn in 2024 and is predicted to reach USD 97.66 Bn by the year 2034 at an 18.8% CAGR during the forecast period for 2025-2034. Synthetic biology is a rapidly advancing scientific discipline focused on repurposing organisms to give them new capabilities. It allows researchers and businesses worldwide to tackle critical issues in manufacturing, agriculture, and med...
Report ID: 2899 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 165
Global Patient Support Programs (PSP) Market Size is valued at USD 21.8 Billion in 2024 and is predicted to reach USD 104.7 Billion by the year 2034 at a 17.1% CAGR during the forecast period for 2025-2034. The patient support programs (PSP) market is a rapidly expanding segment of the healthcare and pharmaceutical industries, driven by an increased emphasis on patient-centric care and the desire to improve treatment outcomes. PSPs are i...
Report ID: 2197 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 179
High Potency Drug Market Size is valued at USD 185.51 Bn in 2024 and is predicted to reach USD 520.73 Bn by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Drugs classified as high potency are those whose active ingredient is highly concentrated or potent and is designed to produce therapeutic effects at low dosages. Dosage forms for high-potency drugs include tablets, capsules, and liquid formulatio...
Report ID: 2505 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Pharmaceutical Contract Sales Outsourcing [CSO] Market Size is valued at USD 10.80 Bn in 2024 and is predicted to reach USD 25.80 Bn by the year 2034 at a 9.2% CAGR during the forecast period for 2025-2034. Pharmaceutical Contract Sales Outsourcing (CSO) refers to the practice of pharmaceutical companies partnering with external organizations to handle various aspects of their sales and marketing efforts. Due to cost reductions...
Report ID: 2063 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Pharmaceuticals